Topchoice Medical Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yi Wang

Algemeen directeur

CN¥623.2k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

CEO

Yi Wang (56 yo)

less than a year

Tenure

CN¥623,200

Compensatie

Ms. Yi Wang has been General Manager at Topchoice Medical Corporation and serves as its Director and serves as its Chairman since 2024. Ms. Wang served as the Chief Financial Officer of Topchoice Medical C...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yi Wang	GM & Chairman	less than a year	CN¥623.20k	geen gegevens
Yuhua Huang	Director	less than a year	geen gegevens	geen gegevens
Weiqian Wang	Director	less than a year	CN¥1.45m	geen gegevens
Min Zhao	Employee Representative to Supervisory Board	13.7yrs	CN¥118.00k	0.00026% CN¥ 57.0k
Jian Ming Lv	Chairman	9.9yrs	geen gegevens	0.65% CN¥ 143.5m
Hui Zhou	Supervisor	3.7yrs	geen gegevens	geen gegevens
Xuqiang Wang	Independent Director	less than a year	geen gegevens	geen gegevens
Shufeng Liu	Independent Director	less than a year	geen gegevens	geen gegevens
Zixuan Lu	Director	less than a year	geen gegevens	geen gegevens
Min Li	Independent Director	less than a year	geen gegevens	0.0070% CN¥ 1.5m

0.6yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 600763 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.6 jaar), wat duidt op een nieuw bestuur.

Topchoice Medical Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Topchoice Medical Co., Inc., Annual General Meeting, Jun 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.42 (vs CN¥0.47 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Topchoice Medical Co., Inc. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 23%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.72 (vs CN¥0.30 in 2Q 2023)

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Topchoice Medical Co., Inc. to Report First Half, 2024 Results on Aug 24, 2024

Topchoice Medical Co., Inc., Annual General Meeting, Jun 20, 2024

First quarter 2024 earnings released: EPS: CN¥0.54 (vs CN¥0.53 in 1Q 2023)

Topchoice Medical Co., Inc. to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment deteriorates as stock falls 15%

Topchoice Medical Co., Inc. (SHSE:600763) completed the acquisition of 6% stake in Zhejiang Topchoice Eye Hospital Investment Management Co., Ltd. from Tong Zhihong.

Topchoice Medical Co., Inc. (SHSE:600763) completed the acquisition of 6% stake in Zhejiang Topchoice Eye Hospital Investment Management Co., Ltd. from Tong Zhihong.

Topchoice Medical Co., Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: CN¥0.65 (vs CN¥0.69 in 3Q 2022)

Topchoice Medical Co., Inc. to Report Q3, 2023 Results on Oct 25, 2023

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: CN¥0.42 (vs CN¥0.40 in 2Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.84 in 3Q 2021)

Investor sentiment improved over the past week

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Investor sentiment improved over the past week

Topchoice Medical Corporation (SHSE:600763) announces an Equity Buyback for CNY 200 million worth of its shares.

Second quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.58 in 2Q 2021)

Investor sentiment deteriorated over the past week

Now 20% undervalued

Investor sentiment improved over the past week

Topchoice Medical Corporation (SHSE:600763) agreed to acquire Heren Health Co., Ltd. (SZSE:300550) from Hangzhou Panyuan Investment Co., Ltd. from Hangzhou Panyuan Investment Co., Ltd. for approximately 770 million.

First quarter 2022 earnings released: EPS: CN¥0.52 (vs CN¥0.51 in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released

Second quarter 2021 earnings released: EPS CN¥0.58 (vs CN¥0.49 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥1.54 (vs CN¥1.44 in FY 2019)

New 90-day low: CN¥232

New 90-day high: CN¥345

New 90-day high: CN¥310

New 90-day high: CN¥284

New 90-day high: CN¥243

New 90-day high: CN¥239

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

Topchoice Medical Corporation to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high - CN¥199

First half earnings released

New 90-day high - CN¥170

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd